ACGN - Aceragen Inc Profile, Share Price, Market Analysis, Charts, Fundamentals

Company Name, Ticker, Competitors, else..

Aceragen Inc (NASDAQ: ACGN)

Sector • Healthcare Industry • Biotechnology & Pharmaceuticals

Industry • Biotechnology & Pharmaceuticals

Sector • Healthcare

Price: $0.0000 $0.00

Day's High:	0.00	Week Perf:
Day's Low:	$ 0.00	30 Day Perf:
Volume (M):	0	52 Wk High:	$ 0.00
Volume (M$):	$ 0	52 Wk Avg:	$0.00
Open:	$0.00	52 Wk Low:	$0.00

ACGN Charts & Quotes

ACGN Charts & Quotes

Company's Segments

Market Capitalization (Millions $)	-
Shares Outstanding (Millions)	7
Employees	70
Revenues (TTM) (Millions $)	7
Net Income (TTM) (Millions $)	-41
Cash Flow (TTM) (Millions $)	-26
Capital Exp. (TTM) (Millions $)	0

Aceragen Inc
Aceragen Inc is a biotechnology company that focuses on developing and commercializing revolutionary RNA interference (RNAi) therapeutics. RNAi is a biological process that can selectively inhibit the expression of target genes, offering potential treatments for a wide range of diseases. Aceragen uses its proprietary technology to discover and optimize RNAi molecules for therapeutic applications. The company aims to provide innovative and effective treatments for diseases where conventional treatments are limited or non-existent.

Company Address: 505 Eagleview Blvd., Suite 212 Exton 19341 PA
Company Phone Number: 348-1600 Stock Exchange / Ticker: NASDAQ ACGN

Reports on Competition

Suppliers At a Glance

Stock Performances by Major Competitors

5 Days	Decrease / Increase

AMGN	-3.79%
BIIB	-4.85%
EXEL	-6.7%
GILD		1.64%
ITOS	-0.39%
SGEN		4.77%
• View Complete Report

ACGN's Valuation	Current
Price to Earnings PE Ratio (TTM)	-
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	-
Price to Sales (Expected)	-
Price to Book	-
PEG (TTM)	-

ACGN's Financial Strength	Current
Quick Ratio	0.12
Working Capital Ratio	0.32
Leverage Ratio (MRQ)	2.48
Total Debt to Equity	0.28
Interest Coverage (TTM)	-
Debt Coverage (TTM)	-

Per Share	Current
Earnings (TTM)	-3.3 $
Revenues (TTM)	0.98 $
Cash Flow (TTM)	-
Cash	0.28 $
Book Value	3.03 $
Dividend (TTM)	0 $

ACGN's Efficiency	Current
Revenue per Employee (TTM)	104,743
Net Income per Employee (TTM)	-586,414
Receivable Turnover Ratio (TTM)	3.5
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	0.1

ACGN's Profitability Ratios	Current
Gross Margin (MRQ)	-
Operating Margin (MRQ)	-834.33 %
Net Margin (MRQ)	-885.3 %
Net Cash Flow Margin (MRQ)	-401.86 %
Effective Tax Rate (TTM)	-

Management Effectiveness	Current
Return On Assets (TTM)	-
Return On Investment (TTM)	-
Return On Equity (TTM)	-
Dividend Yield	-
Pay out Ratio (TTM)	-

ACGN's Valuation
Price to Earnings PE Ratio (TTM)	-
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	-
Price to Sales (Expected)	-
Price to Book	-
PEG (TTM)	-

Per Share
Earnings (TTM)	-3.3 $
Revenues (TTM)	0.98 $
Cash Flow (TTM)	-
Cash	0.28 $
Book Value	3.03 $
Dividend (TTM)	0 $

ACGN's Financial Strength
Quick Ratio	0.12
Working Capital Ratio	0.32
Leverage Ratio (MRQ)	2.48
Total Debt to Equity	0.28
Interest Coverage (TTM)	-
Debt Coverage (TTM)	-

ACGN's Efficiency
Revenue per Employee (TTM)	104,743
Net Income per Employee (TTM)	-586,414
Receivable Turnover Ratio (TTM)	3.5
Inventory Turnover Ratio (TTM)	-
Asset Turnover Ratio (TTM)	0.1

ACGN's Profitability Ratio
Gross Margin (MRQ)	-
Operating Margin (MRQ)	-834.33 %
Net Margin (MRQ)	-885.3 %
Net Cash Flow Margin (MRQ)	-401.86 %
Effective Tax Rate (TTM)	-

Management Effectiveness
Return On Assets (TTM)	-53.23 %
Return On Investment (TTM)	-66.66 %
Return On Equity (TTM)	-215.27 %
Dividend Yield	-
Pay out Ratio (TTM)	-

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

ACGN Company Profile